This chapter examines the application of nanotechnology in medicine, known as nanomedicine, with a focus on the therapeutic application of nanomedicine. The different types of nanomaterials used in nanomedicine will be categorized based on their composition into three categories: solid drug nanoparticles, polymer therapeutics, and nanocarriers.
Professor Doug Brooks and his team have identified a protein called NOX2 oxidase, which is responsible for making reactive oxygen species within cells and this is activated by viruses, including influenza and the rhinovirus, also known as the common cold. They have also identified a new prototype drug that could potentially treat these devastating viral diseases.
Metabesity 2019: Novel therapies that are increasing our understanding of disease and leading to changes in drug development Featuring Stephen Gough, MD, FRCP, SVP Global Chief Medical Officer of Novo Nordisk, Denmark.
If your drug use consists of an occasional aspirin, you may not see the need for serious work on drug delivery. But if you were diabetic, having to inject insulin several times a day, or a cancer patient experiencing debilitating side effects from your treatment, the benefits of improved drug delivery could change your life.